Coastal Infusion Administers Saphnelo^™

Saphnelo (anifrolumab) is used to treat lupus, a chronic autoimmune disease that causes inflammation and damage to various parts of the body. Benlysta is used as an add-on treatment in patients with systemic lupus erythematosus (SLE).

In SLE, a protein called type I interferon is involved in causing the immune system to attack normal cells and tissues. Type I interferon acts by attaching to a protein called type I receptor. The active substance in Saphnelo, anifrolumab, is a monoclonal antibody (another type of protein) designed to attach to this receptor, thereby preventing type I IFN from binding to it. This blocks the action of type I IFN and reduces the inflammation and organ damage that occur in SLE.

What It Treats

Saphnelo is used to treat systemic lupus erythematosus (SLE).

Prescribed By

Saphnelo is most often prescribed by Rheumatologists.

How it's Administered

Saphnelo is administered by intravenous infusion. Saphnelo infusions take about 30 minutes.

Frequency

Saphnelo infusions are given every 4 weeks.

Related Drugs

Benlysta

Additional Resources

The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies